SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-004006
Filing Date
2019-03-13
Accepted
2019-03-13 06:23:20
Documents
49
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_bioxytraninc.htm 10-K 628234
2 CERTIFICATION f10k2018ex31-1_bioxytraninc.htm EX-31.1 8122
3 CERTIFICATION f10k2018ex31-2_bioxytraninc.htm EX-31.2 8108
4 CERTIFICATION f10k2018ex32_bioxytraninc.htm EX-32 4436
  Complete submission text file 0001213900-19-004006.txt   2048975

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE bixt-20181231.xml EX-101.INS 189877
6 XBRL SCHEMA FILE bixt-20181231.xsd EX-101.SCH 28004
7 XBRL CALCULATION FILE bixt-20181231_cal.xml EX-101.CAL 33240
8 XBRL DEFINITION FILE bixt-20181231_def.xml EX-101.DEF 59449
9 XBRL LABEL FILE bixt-20181231_lab.xml EX-101.LAB 169916
10 XBRL PRESENTATION FILE bixt-20181231_pre.xml EX-101.PRE 137239
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 19677032
SIC: 2834 Pharmaceutical Preparations